Cabaletta Bio, Inc. (CABA) Tops Q2 EPS by 8c

Cabaletta Bio, Inc. (NASDAQ: CABA) reported Q2 EPS of ($0.45), $0.08 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Cabaletta Bio, Inc. (CABA) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• BofA turns bearish on Papa John’s, sees limited upside amid fierce competition
• Freedom Holding raises $300M in share offering at $126.35 per share